Prolonged Grief Disorder
Grief is a normal reaction following death (bereavement). Most individuals adequately cope with the distress of bereavement with time and support from their usual networks and others will benefit from support from bereavement services. However, some individuals experience prolonged, elevated levels of bereavement-related distress (1). Such adverse grief reactions have historically been referred to as ‘pathological grief,’ ‘complicated grief,’ or ‘persistent, complex, bereavement disorder’ (2). However, following official classification by the World Health Organisation (3), such reactions are now referred to as ‘prolonged grief disorder’ (PGD).
The two core symptoms of PGD are: a) persistent and intense longing/ yearning for the deceased; and b) persistent and intense preoccupation with the deceased (3). For an official diagnosis of PGD, additional criteria must also be met: i) cultural criterion - the length of the grief reaction must exceed the individual’s cultural expectations; ii) impairment criterion - the grief reaction must cause significant impairment to social or personal functioning; iii) duration criterion - the grief reaction has lasted at least 6 months (3).
It is worth highlighting that whilst the ICD-11 classification system is used in NHS Scotland services, PGD has slightly different criteria in the Diagnostic and Statistical Manual of Mental Health Disorders (4). The two core criteria, impairment criterion, and cultural criterion are the same; however, the duration criterion specifies that the bereavement must have occurred at least 12 months prior to diagnosis for adults, and 6 months prior to diagnosis for children and young people (CYP). This is compared to 6 months of adverse grief reaction specified in the ICD-11. The DSM-V also includes an extra criterion: additional symptoms - at least 3 of 8 additional symptoms must also be present (avoidance, disbelief, numbness etc.).
PGD is associated with significant challenges to both mental and physical health, as well as general functioning. One study reported that 75% of people diagnosed with PGD had comorbid psychiatric conditions, with 62% reporting anxiety disorders, 55% depressive disorders, and 48% post-traumatic stress disorder (PTSD) (5). PGD is also associated with risk-factors for negative impacts on health (hypertension, cardiac events, cancer, immunological dysfunction, suicidality, quality of life, sleep disturbance, and substance use (6)(7)(8)(9) and occupational functioning with higher risk of unemployment (10).
Health and social care service providers should be knowledgeable about the difference between normal grief reactions and adverse reactions that meet the criteria for PGD. They should also be aware that PGD shares some common symptoms with post-traumatic stress disorder (PTSD). Both PGD and PTSD can involve re-experiencing the trauma or loss through intrusive thoughts or memories, avoidance of reminders, and negative emotions (11). However, in cases of PGD compared to PTSD, the trigger is specifically the loss of a significant other rather than a broader range of traumatic events, the negative emotion is more closely linked to yearning and sadness rather than fear, and avoidance is related to reminders of loss rather than threat (11). The Matrix PTSD topic provides further guidance on PTSD.
The following distinctions (from Schute and Stroebe, 2005) can help to identify appropriate treatment following bereavement (12).
-
Universal: Normal Grief Reaction (often seen in primary care): treatment includes information about grief, support groups, counselling.
-
Preventative: Elevated yet sub-clinical levels of PGD symptoms and/or at-risk populations e.g. unexpected or violent death: treatment includes information about grief, support groups, counselling.
-
Indicated: Meets diagnostic criteria for PGD: treatment includes psychological interventions.
For those experiencing normal grief reactions, the evidence suggests that psychological interventions are not effective (13)(14)(15) and information about grief and support groups are recommended.
The evidence supporting preventative psychological interventions (i.e. targeted at individuals with elevated yet sub-clinical levels of PGD symptoms, or individuals ‘at-risk’ of developing PGD, such as individuals who have experienced a violent or unexpected bereavement but do not meet the duration criterion for PGD) has varied findings. The majority of evidence and reviews suggest that preventative psychological interventions are not effective (13)(15)(14)(16). However, a recent randomised control trial (RCT) found that a digital, self-guided, CBT-based preventative intervention was effective at reducing PGD symptoms, with a large effect size compared to a waitlist-control group (17). This suggests that psychological interventions could be effective in the treatment of sub-clinical symptoms and prevention of PGD. However, further research would need to replicate these findings before recommendations about use of psychological interventions for sub-clinical PGD or as a preventative approach (17).
Psychological interventions are recommended for individuals who meet diagnostic criteria for PGD (12) (see overview of evidence below for further details).
PGD is a relatively new disorder classification. Therefore, research into the most appropriate diagnostic criteria and treatment options is still developing. It is therefore recommended that service providers and clinicians consult official, up-to-date diagnostic manuals (3) and remain aware of current developments in research and clinical guidance (18).
There remains a lack of consensus regarding how best to measure PGD. This means that prevalence estimates vary significantly depending on which measurement tool is used (19). Therefore, as research develops, it is possible that future prevalence estimates may differ from current estimates. The current prevalence rate of PGD amongst adults who have experienced bereavement in the U.K is estimated to be between 2.4%-7.9% (11). There are, however, a number of factors which are associated with an increased risk of developing PGD.
Bereavement by ‘unnatural deaths’, particularly suicide and homicide, are associated with prevalence rates of up to 49% (20). Research also shows that ‘younger age of the deceased’ is associated with significantly higher risk of developing PGD, and that this is most significant in the case of reporting the death of a child (20)(11). Lower socio-economic status has also been found to be associated with increased risk of PGD (11)(21), as well as having a history of a mood disorder e.g. bipolar disorder, major depression; (22)(23). Moreover, research suggests that older adults may be more at-risk of developing PGD; however, further research is required to establish this claim (24). Pregnancy loss at any gestational stage represents a traumatic loss, with birth parents exhibiting an elevated risk for developing Prolonged Grief Disorder (PGD). This vulnerability is shaped by multiple factors, including the availability and quality of social support, individual coping mechanisms, and the specific circumstances surrounding the loss. In light of this, comprehensive psychological and trauma informed bereavement care pathways should be integrated into perinatal and maternity services. Recent systematic reviews and clinical guidelines underscore the necessity of early identification and tailored interventions to mitigate the long-term impact of PGD (25).
Research into rates of PGD in children and young people (CYP) in the U.K is lacking; however, according to the ICD-11 (3), prevalence rates for CYP in Europe are estimated to be around 12% (26).
This information is for commissioners, managers, trainers, and health care practitioners to consider the evidence base for the delivery of psychological interventions for people with PGD. This information is also for people diagnosed with PGD, their families, and carers.
This topic introduction page covers evidence-based psychological interventions used to treat PGD in children, young people, and adults, and the psychological practice/settings in which these interventions can be delivered. This topic does not cover pharmacological interventions or interventions which are not informed by psychological theory. There are a wider range of non-psychological interventions and supports that are beyond the scope of this topic and information regarding these interventions can be found at:
NHS Inform: https://www.nhsinform.scot/care-support-and-rights/death-and-bereavement/
Good Life, Good Death, Good Grief: https://www.goodlifedeathgrief.org.uk/
At a Loss: https://www.ataloss.org/ (can be used to identify local / national sources of support - catalogue feature on the site)
National Bereavement Alliance: https://nationalbereavementalliance.org.uk/
Childhood Bereavement Network: https://childhoodbereavementnetwork.org.uk/
National Bereavement Care Pathway for Pregnancy and Baby Loss: https://www.nbcpscotland.org.uk/
NES Bereavement Education Programme Resources for Health and Social Care staff: https://www.sad.scot.nhs.uk/
To be consistent with our focus on interventions with the highest levels of efficacy and the strongest levels of evidence, where these exist, psychological interventions for treating PGD with no evidence and low levels of efficacy have not been included. Non-psychological interventions, such as psychosocial interventions and pharmacological interventions are also not included.
The evidence tables below include interventions with high and moderate levels of evidence (A and B) and moderate to large levels of efficacy. The evidence is obtained from systematic reviews/meta-analyses and RCTs of psychological interventions.
Overview of Evidence for CYP
Due to developmental differences, children and young people can present with different grief reactions to adults. These differences affect treatment design and planning (27), however, there is a lack of research into grief-focused psychological interventions for CYP specifically.
Two recent systematic reviews investigated the effectiveness of psychological interventions for PGD in CYP (28)(27). They found that the overall quality of evidence supporting these interventions is low (28), with only one intervention (CBT Grief-Help (29)) meeting criteria for inclusion in the evidence table (see details below). The overall low quality of evidence can be attributed to a number of methodological and study limitations. These include lack of high-quality RCT’s; lack of follow-up assessments; high risk of bias; and high heterogeneity of measures and outcomes (28)(27).
Moreover, the representativeness of the current research is limited. Many studies focus on mid-adolescent age (excluding younger children and older adolescents), parental death (excluding loss of sibling, friend, or other close relatives), and lack CYP from low-income households and non-western backgrounds. Furthermore, studies tend to exclude CYP with comorbid trauma and mental health conditions, yet in real-world settings, these are common and relevant to treatment (27).
CBT Grief-Help is a CBT-based intervention involving 9 individual child sessions and 5 separate parent sessions (29). Grief-Help significantly reduced PGD symptoms at post-intervention as well as 3, 6 and 12 month follow-up points with medium effect sizes compared to supportive counselling (29). This evidence is supported by results from a feasibility and multiple baseline study (30) as well as a non-randomised open trial (31) - both demonstrating the preliminary efficacy of Grief-Help. Similar to interventions for other disorders in CYP, parental involvement may be a significant factor in improving the effectiveness of PGD interventions for CYP (29)(27). However, further research directly investigating parental involvement would be required to establish this.
Other interventions were reviewed but there was a lack of evidence for inclusion. There is emerging evidence supporting the effectiveness of other psychological interventions in the treatment of PGD in CYP. These include Grief and Trauma-focussed CBT (32); Culturally
-adapted-CBT (33); Trauma and Grief Component Therapy for Adolescents (34)(35); and the Family Bereavement Programme (36). However, the research into these interventions has significant methodological limitations, such as lack of randomisation and control procedures; small, non-representative samples; and the use of out-of-date, heterogenous and proxy measures of PGD. As such, these interventions do not currently meet Matrix criteria.
Overview of Evidence for Adults
There is currently no clinical guidance for the treatment of PGD. Nonetheless, a substantial body of research from RCTs, systematic reviews and meta-analyses supports the efficacy of psychological interventions for PGD in adults (13)(14)(37)(16)(15)(38)(39). The overall quality of this evidence ranges from low - high. Whilst there are many RCTs and meta-analyses conducted to sufficient quality standards, there remains some general methodological limitations in the current research, such as diverse measurement tools, lack of follow-up assessment, and small sample sizes. Moreover, the majority of the research has been carried out on middle-aged, white, female participants (18).
In addition to addressing these limitations mentioned above, researchers recommend further investigation into specific “at-risk” populations such as suicide (40)(41), violent deaths (42), older adults (43), and parents (1). They also recommend further research into various intervention factors such as format, delivery, protocol components, and alternative non-CBT interventions (37)(18). This will help provide a better understanding of what types of interventions work best for which specific groups and individuals.
Initial systematic reviews of grief-focused interventions found that universal and preventative interventions (targeted at people experiencing normal grief reactions or individuals ‘at-risk’ of developing PGD) were not effective at reducing grief symptoms, but that targeted interventions (offered to those with indicated, clinical-level PGD symptoms) were effective with a medium effect size (13)(15). These findings were further supported by a more recent review and meta-analysis by Johannsen and colleagues in 2019, that also demonstrated a medium effect size for psychological interventions (14).
Grief-focused CBT-based approaches
Interventions based on cognitive behavioural principles are the most widely researched interventions for PGD. Most grief-focused CBT protocols are based on Boelen and colleagues’ (2007) cognitive-behavioural conceptualisation of complicated grief (now prolonged grief) (44) . They identify 3 core processes underlying prolonged grief which are targeted by CBT interventions: a) insufficient integration of the loss into autobiographical memory, b) negative global beliefs and misinterpretations of grief reactions, c) anxious and depressive avoidance strategies. Evidence from a recent meta-analysis and systematic review suggests that grief-focused CBT interventions are effective at reducing PGD symptoms with medium - large effect sizes, as well as reducing comorbid PTSD and depressive symptoms with a medium effect size and anxiety symptoms with a small effect size (37). This review included a wide variety of CBT protocols with varying delivery methods, formats, and components - including some interventions with additional components from other therapies, such as eye-movement desensitisation and reprocessing therapy (EMDR) and Interpersonal Therapy (IPT).
Prolonged Grief Therapy
Prolonged Grief Therapy (18)(PGT; previously Complicated Grief Therapy) is the most common and supported intervention for PGD. PGT includes exposure and behavioural activation components from CBT, as well as components from Interpersonal Therapy and Motivational Interviewing. The intervention typically lasts 14-16 sessions. RCTs have demonstrated that PGT is significantly more effective than IPT alone (45) psychotropic medication (46), and supportive counselling (47), and is effective for both the general population and older adults (47)(48)(49). It has also been found to be effective delivered as a group intervention (50) however, there is less evidence evaluating groups than individualised delivery.
CBT for Prolonged Grief
Several RCTs also demonstrate the efficacy of standard, individualised CBT interventions (without additional non-CBT components) (44)(51). These interventions involve a mixture of cognitive restructuring, behavioural activation, and exposure components - lasting between 12-24 sessions. They have been found to have a medium-large effect on PGD symptoms when compared to supportive counselling or waitlist control groups (37).
Digital, guided CBT (with feedback)
Several RCTs have assessed the efficacy of guided, digital CBT interventions and these have been summarised in a meta-analysis (38). The protocols are grief-adapted versions of Cognitive Therapy for PTSD protocols (52)(53), and are based on principles from the Pennebaker Writing Paradigm (54). Most protocols also tend to include additional adaptations depending on the type of loss (e.g. suicide, cancer or perinatal bereavement). They typically involve 1-2 written assignments per week, each lasting 20-45 minutes over a period of 5-7 weeks (typically 10 assignments in total). The research suggests that receiving individualised feedback from a trained therapist on each writing assignments is essential to the effectiveness of the intervention (38). They have been found to be effective at reducing PGD symptoms with a range of medium-large effect sizes. Whilst these are similar effect sizes to those found in face-to-face CBT, digital CBT interventions have only been compared to wait-list control groups which can lead to inflated effect size estimates.
Group Interventions
Maass and colleagues (2022) conducted a systematic review and meta-analysis of bereavement groups based on varied principles, concluding that the evidence base is weak (16). From the 14 RCTs included in their study, they found that bereavement groups were only marginally more effective than control groups at post-intervention, but not more effective at follow-up.
Mindfulness-based cognitive therapy
Bryant et al. (2024) compared grief-focused CBT to mindfulness-based cognitive therapy (MBCT) (55). They found that both grief-focused CBT and MBCT lead to significant reductions in PGD symptoms at post-intervention with large effect sizes. However, at 6 months post-intervention, they found that grief-focused CBT demonstrated significantly greater reductions in PGD symptoms compared to MBCT. Thus, MBCT presents a legitimately effective alternative to CBT, however, CBT may be favoured as a first line recommendation.
Suicide Bereavement
Individuals bereaved by suicide are at elevated risk of developing PGD (41). Two systematic reviews investigated the effectiveness of psychological interventions for individuals bereaved by suicide (40)(41). Both reviews concluded that the evidence is mixed and inconclusive. This may be due to the fact that many of the studies included in these reviews were preventive interventions (targeted at individuals who do not currently meet the criteria for PGD diagnosis but are deemed “at-risk”), which have typically been found to be ineffective at treating PGD (14).
Other Interventions - reviewed but lack sufficient evidence
The following interventions show promising results for treating PGD: eye movement desensitisation and reprocessing therapy (EMDR) (56)(57)(58)(59); narrative reconstruction therapy (60)(61); meaning-centred grief psychotherapy (62)(63); present-centred psychotherapy (64). However, the evidence supporting these interventions is only preliminary, and is currently insufficient to be included in Matrix recommendations.
Overview of evidence for Older Adults
Older adults may be at higher risk of developing PGD due to social isolation, higher rates of comorbidity, and increased exposure to loss and bereavement (43). In their systematic review, Roberts and colleagues (2019) identified 12 grief-focused interventions targeted at older adults (43). Only 2 of these studies were of sufficient quality to draw evidence from and both of these demonstrated the efficacy of Prolonged Grief Therapy for older adults (47)(48). Other interventions such as Metacognitive Therapy for prolonged grief and (65); Dual-Process Bereavement Group Intervention (66) and Family-focused Grief Therapy (67) show promising results but require further research to be included as a recommendation in the Matrix. Clinicians are advised that there are differences in presentation of psychological problems in later life and to consult Delivering Effective Psychological Therapies and Interventions to Older People for further information on factors relevant to practice.
Overview of Evidence for Harms and Adverse Effects
Like all treatments, psychological therapies also have the potential to have adverse effects. Until recently, information on potential harms and rates of adverse effects have not been gathered systematically (see information relating to safety in the delivery of psychological therapies). Although reports of adverse effects are increasingly included in research trials and gathered as part of service provision we do not know if psychological interventions cause more, fewer or similar numbers of adverse effects than no treatment or another treatment, because the evidence in this area is of very low quality at present.
Recommendation |
Who for? |
List of Interventions |
Type of psychological practice
|
Evidence |
Efficacy |
First line recommendation
|
All levels Age 8-18 and caregivers
|
CBT “Grief Help” Individualised, face-to-face (9 sessions + 5 counselling sessions with caregiver) |
Specialist |
A |
Medium |
Recommendation |
Who for? |
List of Interventions |
Type of psychological practice
|
Evidence |
Efficacy |
First Line |
Adults presenting with prolonged grief |
Prolonged Grief Therapy (14-16 sessions)
|
Enhanced/Specialist |
A |
Medium - large |
First Line |
Adults presenting with prolonged grief |
Grief-focused CBT Individual, face-to-face (12-24 sessions) |
Specialist |
A |
Medium - large |
Alternative (weaker evidence) |
Adults presenting with prolonged grief |
Digital, guided CBT with therapist feedback 10-12 assignments |
Enhanced/Specialist |
A
|
Medium - large |
Alternative (less evidence) |
Adults presenting with prolonged grief |
Group-based Prolonged Grief Therapy Face-to-face (14-16 sessions) |
Enhanced/Specialist |
A |
Medium - large |
Alternative (less evidence) |
Adults presenting with prolonged grief |
Mindfulness-based Cognitive Therapy Individual, face-to-face 12 sessions |
Enhanced/Specialist |
B |
Large |
Advisory Group: Paul Graham, Debbie-Jo March, Steven Millar, Janice Nicholson, Leeanne Nicklas, Marie-Claire Shankland, Clare Tucker.
Technical Group: Steven Millar, Leeanne Nicklas, Marie Claire Shankland
1.Szuhany K.L., Malgaroli M., Miron C.D., Simon NM. Prolonged grief disorder: Course, diagnosis, assessment, and treatment. Focus (United States) 2021;19(2):161–172.
2.Maciejewski PK, Maercker A, Boelen PA, Prigerson HG. "Prolonged grief disorder" and "persistent complex bereavement disorder", but not "complicated grief", are one and the same diagnostic entity: an analysis of data from the Yale Bereavement Study. World Psychiatry 2016 -10;15(3):266–275.
3.World Health Organization. International classification of diseases (11th revision). 2018.
4.Heeke C, Kampisiou C, Niemeyer H, Knaevelsrud C. A systematic review and meta-analysis of correlates of prolonged grief disorder in adults exposed to violent loss. European Journal of Psychotraumatology 2017;8(Suppl 6):ArtID 1583524.
5.Chen J.H., Bierhals A.J., Prigerson H.G., Kasl S.V., Mazure C.M., Jacobs S. Gender differences in the effects of bereavement-related psychological distress in health outcomes. Psychol Med 1999;29(2):367–380.
6.Lancel M., Stroebe M., Eisma MC. Sleep disturbances in bereavement: A systematic review. Sleep Medicine Reviews 2020;53(pagination):Article Number: 101331. Date of Publication: 01 Oct 2020.
7.Latham A.E., Prigerson HG. Suicidality and bereavement: Complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide and Life-Threatening Behavior 2004;34(4):350–362.
8.Parisi A., Sharma A., Howard M.O., Blank Wilson A. The relationship between substance misuse and complicated grief: A systematic review. J Subst Abuse Treat 2019;103:43–57.
9.Stephen A.I., Macduff C., Petrie D.J., Tseng F.M., Schut H., Skar S., et al. The economic cost of bereavement in Scotland. Death Stud 2015;39(1-5):151–157.
10.Shevlin M., Redican E., Hyland P., Murphy J., Karatzias T., McBride O., et al. Symptoms and levels of ICD-11 Prolonged Grief Disorder in a representative community sample of UK adults. Soc Psychiatry Psychiatr Epidemiol 2023;58(10):1535–1547.
11.Schut H., Stroebe M S, editors. Interventions to enhance adaptation to bereavementMary Ann Liebert Inc. (140 Huguenot Street, New Rochelle, United States); 2005.
12.Currier JM, Holland JM, Neimeyer RA. Do CBT-based interventions alleviate distress following bereavement? A review of the current evidence. International Journal of Cognitive Therapy 2010;3(1):77–93.
13.Johannsen M., Damholdt M.F., Zachariae R., Lundorff M., FarverVestergaard I., O'Connor M. Psychological interventions for grief in adults: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 2019;253:69–86.
14.Wittouck C., Van Autreve S., De Jaegere E., Portzky G., van Heeringen K. The prevention and treatment of complicated grief: A meta-analysis. Clin Psychol Rev 2011;31(1):69–78.
15.Maass U., Hofmann L., Perlinger J., Wagner B. Effects of bereavement groups-a systematic review and meta-analysis. Death Stud 2022;46(3):708–718.
16.Reitsma L., Boelen P.A., de Keijser J., Lenferink LIM. Self-guided online treatment of disturbed grief, posttraumatic stress, and depression in adults bereaved during the COVID-19 pandemic: A randomized controlled trial. Behav Res Ther 2023;163(pagination):Article Number: 104286. Date of Publication: 01 Ar 2023.
17.Simon NM, Shear MK. Prolonged Grief Disorder. New England Journal of Medicine 2024 -10-02;391(13):1227–1236.
18.Treml J., Kaiser J., Plexnies A., Kersting A. Assessing prolonged grief disorder: A systematic review of assessment instruments. J Affect Disord 2020;274:420–434.
19.Djelantik A.A.A.M.J., Smid G.E., Mroz A., Kleber R.J., Boelen PA. The prevalence of prolonged grief disorder in bereaved individuals following unnatural losses: Systematic review and meta regression analysis. J Affect Disord 2020;265:146–156.
20.Kersting A., Brahler E., Glaesmer H., Wagner B. Prevalence of complicated grief in a representative population-based sample. J Affect Disord 2011;131(1-3):339–343.
21.Simon N.M., Shear K.M., Thompson E.H., Zalta A.K., Perlman C., Reynolds C.F., et al. The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry 2007;48(5):395–399.
22.Sung S.C., Dryman M.T., Marks E., Shear M.K., Ghesquiere A., Fava M., et al. Complicated grief among individuals with major depression: Prevalence, comorbidity, and associated features. J Affect Disord 2011;134(1-3):453–458.
23.Lundorff M., Holmgren H., Zachariae R., FarverVestergaard I., O'Connor M. Prevalence of prolonged grief disorder in adult bereavement: A systematic review and meta-analysis. J Affect Disord 2017;212:138–149.
24.Zhang X., Chen Y., Zhao M., Yuan M., Zeng T., Wu M. Complicated grief following the perinatal loss: a systematic review. BMC Pregnancy and Childbirth 2024;24(1) (pagination):Article Number: 772. Date of Publication: 01 Dec 2024.
25.Boelen P.A., Spuij M., Reijntjes AHA. Prolonged grief and posttraumatic stress in bereaved children: A latent class analysis. Psychiatry Res 2017;258:518–524.
26.Saladino V, Verrastro V, Calaresi D, Barberis N. The effectiveness of cognitive behavioral therapy for prolonged grief symptoms in children and adolescents: A systematic review. International Journal of Stress Management 2024;31(1):66–85.
27.Breen L.J., Greene D., Rees C.S., Black A., Cawthorne M., Egan SJ. A co-designed systematic review and meta-analysis of the efficacy of grief interventions for anxiety and depression in young people. J Affect Disord 2023;335:289–297.
28.Boelen P.A., Lenferink L.I.M., Spuij M. CBT for Prolonged grief in children and adolescents: A randomized clinical trial. Am J Psychiatry 2021;178(4):294–304.
29.Spuij M., Van LondenHuiberts A., Boelen PA. Cognitive-Behavioral Therapy for Prolonged Grief in Children: Feasibility and Multiple Baseline Study. Cognitive and Behavioral Practice 2013;20(3):349–361.
30.Spuij M., Dekovic M., Boelen PA. An open trial of 'grief-help': a cognitive-behavioural treatment for prolonged grief in children and adolescents. Clinical psychology & psychotherapy 2015;22(2):185–192.
31.Cohen JA, Mannarino AP, Deblinger E. Treating trauma and traumatic grief in children and adolescents., 2nd ed. (2017).Treating trauma and traumatic grief in children and adolescents.xix, 356 pp New York, NY, US: The Guilford Press; US.
32.Thurman T.R., Luckett B.G., Nice J., Spyrelis A., Taylor TM. Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa. The Lancet Global Health 2017;5(6):e604–e614.
33.Alvis L, Oosterhoff B, Giang C, Kaplow JB. A pilot open trial of an individualized adaptation of trauma and grief component therapy (TGCT) in children and adolescents. Child & Youth Care Forum 2024;53(4):893–908.
34.Saltzman W, Layne C, Pynoos R, Olafson E, Kaplow J, Boat B. Trauma and Grief Component Therapy for Adolescents: A Modular Approach to Treating Traumatized and Bereaved Youth. Cambridge: Cambridge University Press; 2017.
35.Sandler I.N., Ma Y., Tein J.Y., Ayers T.S., Wolchik S., Kennedy C., et al. Long-Term Effects of the Family Bereavement Program on Multiple Indicators of Grief in Parentally Bereaved Children and Adolescents. J Consult Clin Psychol 2010;78(2):131–143.
36.KomischkeKonnerup K.B., Zachariae R., Boelen P.A., Marello M.M., O'Connor M. Grief-Focused Cognitive Behavioral Therapies for Prolonged Grief Symptoms: A Systematic Review and Meta-Analysis. J Consult Clin Psychol 2024;92(4):236–248.
37.Wagner B., Rosenberg N., Hofmann L., Maass U. Web-based bereavement care: A systematic review and meta-analysis. Frontiers in Psychiatry 2020;11(pagination):Article Number: 525. Date of Publication: 2020.
38.Zuelke A.E., Luppa M., Lobner M., Pabst A., Schlapke C., Stein J., et al. Effectiveness and Feasibility of Internet-Based Interventions for Grief after Bereavement: Systematic Review and Meta-analysis. JMIR Mental Health 2021;8(12) (pagination):Article Number: e29661. Date of Publication: 01 Dec 2021.
39.Andriessen K., Krysinska K., Hill N.T.M., Reifels L., Robinson J., Reavley N., et al. Effectiveness of interventions for people bereaved through suicide: A systematic review of controlled studies of grief, psychosocial and suicide-related outcomes. BMC Psychiatry 2019;19(1) (pagination):Article Number: 49. Date of Publication: 30 Jan 2019.
40.Linde K., Treml J., Steinig J., Nagl M., Kersting A. Grief interventions for people bereaved by suicide: A systematic review. PLoS ONE 2017;12(6) (pagination):Article Number: e0179496. Date of Publication: 01 Jun 2017.
41.AlvesCosta F., HamiltonGiachritsis C., Christie H., van Denderen M., Halligan S. Psychological Interventions for Individuals Bereaved by Homicide: A Systematic Review. Trauma, violence & abuse 2021;22(4):793–803.
42.Roberts KE, Walsh LE, Saracino RM, Fogarty J, Coats T, Goldberg J, et al. A Systematic Review of Treatment Options for Grieving Older Adults. Current treatment options in psychiatry 2019 Dec;6(4):422–449.
43.Boelen P.A., Prigerson HG. The influence of symptoms of prolonged grief disorder, depression, and anxiety on quality of life among bereaved adults: A prospective study. Eur Arch Psychiatry Clin Neurosci 2007;257(8):444–452.
44.Shear K., Frank E., Houck P.R., Reynolds CF. Treatment of complicated grief: A randomized controlled trial. JAMA 2005;293(21):2601–2608.
45.Shear M.K., Reynolds C.F., Simon N.M., Zisook S., Wang Y., Mauro C., et al. Optimizing treatment of complicated grief a randomized clinical trial. JAMA Psychiatry 2016;73(7):685–694.
46.Nam I. Complicated Grief Treatment for older adults: The critical role of a supportive person. Psychiatry Res 2016;244:97–102.
47.Shear M.K., Wang Y., Skritskaya N., Duan N., Mauro C., Ghesquiere A. Treatment of complicated grief in elderly persons: A randomized clinical trial. JAMA Psychiatry 2014;71(11):1287–1295.
48.Supiano K.P., Luptak M. Complicated grief in older adults: a randomized controlled trial of complicated grief group therapy. Gerontologist 2014;54(5):840–856.
49.Lacasta M.A., Cruzado JA. Effectiveness of a cognitive-behavioral group therapy for complicated grief in relatives of patients with cancer: A randomized clinical trial. Palliative & supportive care 2024;22(5):954–960.
50.Rosner R., Pfoh G., Kotoucova M., Hagl M. Efficacy of an outpatient treatment for prolonged grief disorder: A randomized controlled clinical trial. J Affect Disord 2014;167:56–63.
51.Lange A., Rietdijk D., Hudcovicova M., Van de Ven J.P., Schrieken B., Emmelkamp PMG. Interapy: A controlled randomized trial of the standardized treatment of posttraumatic stress through the internet. J Consult Clin Psychol 2003;71(5):901–909.
52.Pennebaker JW. Writing about emotional experiences as a therapeutic process. 1997 -05.
53.Bryant R.A., Azevedo S., Yadav S., Cahill C., Kenny L., Maccallum F., et al. Cognitive Behavior Therapy vs Mindfulness in Treatment of Prolonged Grief Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2024;81(7):646–654.
54.Lenferink LIM, de Keijser J, Smid GE, Boelen PA. Cognitive therapy and EMDR for reducing psychopathology in bereaved people after the MH17 plane crash: Findings from a randomized controlled trial. Traumatology 2020;26(4):427–437.
55.Meysner L, Cotter P, Lee CW. Evaluating the efficacy of EMDR with grieving individuals: A randomized control trial. Journal of EMDR Practice and Research 2016;10(1):2–12.
56.van Denderen M., de Keijser J., Stewart R., Boelen PA. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: A randomized controlled trial. Clinical psychology & psychotherapy 2018(pagination):Date of Publication: 26 Feb 2018.
57.Spicer L. Eye Movement Desensitisation and Reprocessing (EMDR) therapy for prolonged grief: theory, research, and practice. Frontiers in Psychiatry 2024;15(pagination):Article Number: 1357390. Date of Publication: 2024.
58.Elinger G., HassonOhayon I., BarShachar Y., Peri T. A quasi-experimental trial of narrative reconstruction for prolonged grief disorder: Symptomatic improvement and enhanced memory integration. J Clin Psychol 2023;79(12):2849–2868.
59.Elinger G, Hasson-Ohayon I, Barkalifa E, Boelen PA, Peri T. Narrative reconstruction therapy for prolonged grief disorder - a pilot study. European Journal of Psychotraumatology 2021 Mar 30;12(1):1896126.
60.Lichtenthal W.G., Catarozoli C., Masterson M., Slivjak E., Schofield E., Roberts K.E., et al. An open trial of meaning-centered grief therapy: Rationale and preliminary evaluation. Palliative & supportive care 2019;17(1):2–12.
61.Neimeyer RA. Meaning reconstruction in bereavement: Development of a research program. Death Stud 2019;43(2):79–91.
62.Rosner R., Rau J., Kersting A., Rief W., Steil R., Rummel A.M., et al. Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy: A Randomized Clinical Trial. JAMA Psychiatry 2025;82(2):109–117.
63.Wenn J.A., O'Connor M., Kane R.T., Rees C.S., Breen LJ. A pilot randomised controlled trial of metacognitive therapy for prolonged grief. BMJ Open 2019;9(1) (pagination):Article Number: 21409. Date of Publication: 01 Jan 2019.
64.Chow A.Y.M., Caserta M., Lund D., Suen M.H.P., Xiu D., Chan I.K.N., et al. Dual-Process Bereavement Group Intervention (DPBGI) for Widowed Older Adults. Gerontologist 2019;59(5):983–994.
65.Kissane D.W., McKenzie M., Bloch S., Moskowitz C., McKenzie D.P., O'Neill I. Family focused grief therapy: A randomized, controlled trial in palliative care and bereavement. Am J Psychiatry 2006;163(7):1208–1218.